XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Derivatives (Tables)
9 Months Ended
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Primary Risks Managed by Derivatives
The following table presents the primary underlying risk exposure, gross notional amount and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:
September 30, 2024December 31, 2023
Primary Underlying Risk ExposureGross
Notional
Amount
Estimated Fair ValueGross
Notional
Amount
Estimated Fair Value
AssetsLiabilitiesAssetsLiabilities
(In millions)
Derivatives Designated as Hedging Instruments:
Fair value hedges:
Interest rate swapsInterest rate$5,188 $1,134 $554 $4,550 $1,257 $535 
Foreign currency swapsForeign currency exchange rate1,664 43 1,475 55 — 
Foreign currency forwardsForeign currency exchange rate350 — 69 450 — 65 
Subtotal7,202 1,177 630 6,475 1,312 600 
Cash flow hedges:
Interest rate swapsInterest rate4,155 — 259 4,156 265 
Interest rate forwardsInterest rate5,090 59 923 6,115 51 938 
Foreign currency swapsForeign currency exchange rate45,985 2,458 1,655 43,906 2,457 1,509 
Subtotal55,230 2,517 2,837 54,177 2,509 2,712 
Net investment in a foreign operation hedges:
Foreign currency forwardsForeign currency exchange rate205 — 503 — 
Currency optionsForeign currency exchange rate3,000 412 — 3,000 394 — 
Subtotal3,205 419 — 3,503 394 
Total qualifying hedges65,637 4,113 3,467 64,155 4,215 3,320 
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate swapsInterest rate29,675 1,654 1,062 29,801 1,497 1,102 
Interest rate floorsInterest rate9,228 48 — 15,321 41 — 
Interest rate capsInterest rate29,052 130 30,016 373 — 
Interest rate futuresInterest rate1,732 1,243 
Interest rate optionsInterest rate43,481 269 119 43,926 385 103 
Interest rate forwardsInterest rate2,934 130 76 2,383 69 36 
Synthetic GICsInterest rate49,081 — — 49,066 — — 
Foreign currency swapsForeign currency exchange rate10,755 981 231 11,891 1,200 356 
Foreign currency forwardsForeign currency exchange rate13,511 283 961 14,128 310 806 
Currency futuresForeign currency exchange rate321 — 314 — 
Currency optionsForeign currency exchange rate— — — 50 — — 
Credit default swaps — purchasedCredit2,801 74 2,877 79 
Credit default swaps — writtenCredit12,851 267 12,468 233 
Equity futuresEquity market1,866 13 2,163 11 
Equity index optionsEquity market14,106 276 263 19,421 399 255 
Equity variance swapsEquity market114 — 99 — 
Equity total return swapsEquity market2,301 — 90 1,912 218 
Longevity swaps (1)
Longevity1,000 — — — — — 
Total non-designated or nonqualifying derivatives224,809 4,059 2,890 237,079 4,522 2,978 
Total$290,446 $8,172 $6,357 $301,234 $8,737 $6,298 
__________________
(1)Longevity swaps are used by the Company to mitigate risk associated with life expectancy and unanticipated changes in mortality rates.
Included in the table above, the Company uses various over-the-counter (“OTC”) and exchange traded derivatives to hedge variable annuity guarantees. The table below presents the gross notional amount, estimated fair value and primary underlying risk exposure of the derivatives hedging variable annuity guarantees accounted for as MRBs:
September 30, 2024December 31, 2023
Primary Underlying Risk ExposureGross
Notional
Amount
Estimated Fair ValueGross
Notional
Amount
Estimated Fair Value
AssetsLiabilitiesAssetsLiabilities
(In millions)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate$9,092 $13 $603 $9,096 $13 $663 
Foreign currency exchange rate577 20 716 22 
Equity market4,659 94 193 5,189 77 373 
$14,328 $127 $797 $15,001 $112 $1,038 
The Effects of Derivatives on the Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
The following table presents the interim condensed consolidated financial statement location and amount of gain (loss) recognized on fair value, cash flow, net investment in a foreign operation (“NIFO”), nonqualifying hedging relationships and embedded derivatives:
Three Months Ended September 30, 2024
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)$(1)$— N/A$185 $92 $— N/A
Hedged items— N/A(191)(93)— N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)(23)41 N/A— 32 — N/A
Hedged items22 (30)N/A— (34)— N/A
Amount excluded from the assessment of hedge effectiveness— (15)N/A— — — N/A
Subtotal
(1)(4)N/A(6)(3)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A$286 
Amount of gains (losses) reclassified from AOCI into income(1)— — — — (4)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A(161)
Amount of gains (losses) reclassified from AOCI into income602 — — — — (603)
Foreign currency transaction gains (losses) on hedged items— (585)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — — — 
Subtotal
16 — — — — (482)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A(141)
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A(33)
Subtotal
N/A— N/AN/AN/AN/A(174)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)— N/A360 N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)— N/A573 N/AN/AN/AN/A
Credit derivatives — purchased (1)— N/A(8)N/AN/AN/AN/A
Credit derivatives — written (1)— N/A25 N/AN/AN/AN/A
Equity derivatives (1)(10)N/A(95)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items— N/A(182)N/AN/AN/AN/A
Subtotal
(10)N/A673 N/AN/AN/AN/A
Earned income on derivatives33 — 136 (5)(36)— — 
Synthetic GICsN/AN/A19 N/AN/AN/AN/A
Embedded derivativesN/AN/A(61)N/AN/AN/AN/A
Total
$28 $12 $767 $(11)$(39)$— $(656)
Three Months Ended September 30, 2023
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)$(2)$— N/A$(230)$(60)$— N/A
Hedged items— N/A223 59 — N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)12 (19)N/A— (27)— N/A
Hedged items(12)14 N/A— 26 — N/A
Amount excluded from the assessment of hedge effectiveness— (2)N/A— — — N/A
Subtotal
(7)N/A(7)(2)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A$(711)
Amount of gains (losses) reclassified from AOCI into income11 17 — — — — (28)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A(293)
Amount of gains (losses) reclassified from AOCI into income(301)— — — 299 
Foreign currency transaction gains (losses) on hedged items— 288 — — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — — — 
Subtotal
12 — — — (733)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/AN/AN/AN/AN/A74 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A10 
Subtotal
N/AN/AN/AN/AN/A84 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)— N/A(1,105)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)— N/A(556)N/AN/AN/AN/A
Credit derivatives — purchased (1)— N/A30 N/AN/AN/AN/A
Credit derivatives — written (1)— N/A(40)N/AN/AN/AN/A
Equity derivatives (1)N/A120 N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items— N/A13 N/AN/AN/AN/A
Subtotal
N/A(1,538)N/AN/AN/AN/A
Earned income on derivatives82 — 230 (3)(43)— — 
Synthetic GICsN/AN/A20 N/AN/AN/AN/A
Embedded derivativesN/AN/A86 N/AN/AN/AN/A
Total
$103 $$(1,202)$(10)$(45)$$(649)
Nine Months Ended September 30, 2024
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$(1)$— N/A$35 $34 $— N/A
Hedged items
— N/A(54)(38)— N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
(21)(16)N/A— — N/A
Hedged items
22 12 N/A— — N/A
Amount excluded from the assessment of hedge effectiveness
— (11)N/A— — — N/A
Subtotal
(15)N/A(19)(2)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$(196)
Amount of gains (losses) reclassified from AOCI into income
18 (2)— — — — (16)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A(180)
Amount of gains (losses) reclassified from AOCI into income
226 — — — — (230)
Foreign currency transaction gains (losses) on hedged items
— (236)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income
— — — — — (1)
Subtotal
22 (11)— — — — (623)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A203 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A
Subtotal
N/A— N/AN/AN/AN/A207 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A(211)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A(697)N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/A(6)N/AN/AN/AN/A
Credit derivatives — written (1)
— N/A47 N/AN/AN/AN/A
Equity derivatives (1)
(46)N/A(545)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A159 N/AN/AN/AN/A
Subtotal
(46)N/A(1,253)N/AN/AN/AN/A
Earned income on derivatives
116 — 497 (11)(129)— — 
Synthetic GICsN/AN/A57 N/AN/AN/AN/A
Embedded derivativesN/AN/A(21)N/AN/AN/AN/A
Total
$93 $(26)$(720)$(30)$(131)$— $(416)
Nine Months Ended September 30, 2023
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$(3)$— N/A$(239)$(59)$— N/A
Hedged items
— N/A218 57 — N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
(10)(73)N/A— (14)— N/A
Hedged items
56 N/A— 15 — N/A
Amount excluded from the assessment of hedge effectiveness
— (2)N/A— — — N/A
Subtotal
(1)(19)N/A(21)(1)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$(369)
Amount of gains (losses) reclassified from AOCI into income
38 77 — — — — (115)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A(715)
Amount of gains (losses) reclassified from AOCI into income
10 — — — (15)
Foreign currency transaction gains (losses) on hedged items
— (2)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A(1)
Amount of gains (losses) reclassified from AOCI into income
— — — — — — — 
Subtotal
41 85 — — — (1,215)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/AN/AN/AN/AN/A280 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A37 
Subtotal
N/AN/AN/AN/AN/A317 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A(1,381)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A(1,518)N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/A(1)N/AN/AN/AN/A
Credit derivatives — written (1)
— N/A48 N/AN/AN/AN/A
Equity derivatives (1)
(34)N/A(801)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A455 N/AN/AN/AN/A
Subtotal
(34)N/A(3,198)N/AN/AN/AN/A
Earned income on derivatives
157 — 802 (111)— — 
Synthetic GICsN/AN/A56 N/AN/AN/AN/A
Embedded derivativesN/AN/A51 N/AN/AN/AN/A
Total
$163 $71 $(2,289)$(16)$(112)$$(898)
__________________
(1)Excludes earned income on derivatives.
Fair Value Hedges
The following table presents the balance sheet classification, carrying amount and cumulative fair value hedging adjustments for items designated and qualifying as hedged items in fair value hedges:
Balance Sheet Line ItemCarrying Amount
 of the Hedged
Assets/(Liabilities)
Cumulative Amount
of Fair Value Hedging Adjustments
Included in the Carrying Amount of Hedged
Assets/(Liabilities) (1)
September 30, 2024December 31, 2023September 30, 2024December 31, 2023
(In millions)
Fixed maturity securities AFS$388 $454 $— $
Mortgage loans$305 $359 $(2)$(11)
FPBs
$(2,750)$(2,863)$151 $191 
PABs
$(2,438)$(1,911)$43 $25 
__________________
(1)Includes ($96) million and ($111) million of hedging adjustments on discontinued hedging relationships at September 30, 2024 and December 31, 2023, respectively.
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
September 30, 2024December 31, 2023
Rating Agency Designation of Referenced
Credit Obligations (1)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (3)
$$103 1.3$$150 1.6
Credit default swaps referencing indices
83 4,261 2.480 3,830 2.7
Subtotal
84 4,364 2.482 3,980 2.6
Baa
Single name credit default swaps (3)
92 1.699 2.1
Credit default swaps referencing indices
169 8,195 5.0145 8,188 5.4
Subtotal
170 8,287 5.0146 8,287 5.3
Ba
Single name credit default swaps (3)
— 17 1.4— 17 2.1
Credit default swaps referencing indices
24 2.225 3.0
Subtotal
41 1.942 2.6
B
Credit default swaps referencing indices
10 144 3.9129 5.0
Subtotal
10 144 3.9129 5.0
Caa
Credit default swaps referencing indices
(1)15 2.2(4)30 2.5
Subtotal
(1)15 2.2(4)30 2.5
Total
$265 $12,851 4.1$228 $12,468 4.5
_________________
(1)The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), S&P Global Ratings (“S&P”) and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.
(2)The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.
(3)Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or municipals.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
September 30, 2024December 31, 2023
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$8,111 $6,036 $8,749 $6,014 
OTC-cleared (1)
191 260 158 277 
Exchange-traded
17 11 16 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
8,319 6,304 8,918 6,307 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,035)(3,035)(3,568)(3,568)
OTC-cleared
(5)(5)(5)(5)
Exchange-traded
(3)(3)(1)(1)
Cash collateral: (3), (4)
OTC-bilateral
(2,676)— (3,448)— 
OTC-cleared
(181)(237)(150)(239)
Exchange-traded
— (4)— (5)
Securities collateral: (5)
OTC-bilateral
(2,313)(2,993)(1,563)(2,427)
OTC-cleared
— (18)— (33)
Exchange-traded
— (1)— (10)
Net amount after application of master netting agreements and collateral
$106 $$183 $19 
__________________
(1)At September 30, 2024 and December 31, 2023, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $147 million and $181 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of ($53) million and $9 million, respectively.
(2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At September 30, 2024 and December 31, 2023, the Company received excess cash collateral of $43 million and $163 million, respectively, and provided excess cash collateral of $93 million and $98 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at September 30, 2024, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At September 30, 2024 and December 31, 2023, the Company received excess securities collateral with an estimated fair value of $441 million and $298 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At September 30, 2024 and December 31, 2023, the Company provided excess securities collateral with an estimated fair value of $1.5 billion, at both periods, for its OTC-bilateral derivatives, $891 million and $945 million, respectively, for its OTC-cleared derivatives, and $181 million and $137 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
September 30, 2024December 31, 2023
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$8,111 $6,036 $8,749 $6,014 
OTC-cleared (1)
191 260 158 277 
Exchange-traded
17 11 16 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
8,319 6,304 8,918 6,307 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,035)(3,035)(3,568)(3,568)
OTC-cleared
(5)(5)(5)(5)
Exchange-traded
(3)(3)(1)(1)
Cash collateral: (3), (4)
OTC-bilateral
(2,676)— (3,448)— 
OTC-cleared
(181)(237)(150)(239)
Exchange-traded
— (4)— (5)
Securities collateral: (5)
OTC-bilateral
(2,313)(2,993)(1,563)(2,427)
OTC-cleared
— (18)— (33)
Exchange-traded
— (1)— (10)
Net amount after application of master netting agreements and collateral
$106 $$183 $19 
__________________
(1)At September 30, 2024 and December 31, 2023, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $147 million and $181 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of ($53) million and $9 million, respectively.
(2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At September 30, 2024 and December 31, 2023, the Company received excess cash collateral of $43 million and $163 million, respectively, and provided excess cash collateral of $93 million and $98 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at September 30, 2024, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At September 30, 2024 and December 31, 2023, the Company received excess securities collateral with an estimated fair value of $441 million and $298 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At September 30, 2024 and December 31, 2023, the Company provided excess securities collateral with an estimated fair value of $1.5 billion, at both periods, for its OTC-bilateral derivatives, $891 million and $945 million, respectively, for its OTC-cleared derivatives, and $181 million and $137 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of OTC-bilateral derivatives after considering effect of netting agreements
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
September 30, 2024December 31, 2023
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position (1)$2,954 $47 $3,001 $2,443 $$2,447 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$3,612 $53 $3,665 $3,011 $$3,017 
__________________
(1)After taking into consideration the existence of netting agreements.
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationSeptember 30, 2024December 31, 2023
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld and guarantees on reinsurance
Other liabilities$(53)$(70)
Fixed annuities with equity indexed returns
PABs
172 163 
Total
$119 $93 
Embedded Derivatives
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
September 30, 2024December 31, 2023
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position (1)$2,954 $47 $3,001 $2,443 $$2,447 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$3,612 $53 $3,665 $3,011 $$3,017 
__________________
(1)After taking into consideration the existence of netting agreements.
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationSeptember 30, 2024December 31, 2023
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld and guarantees on reinsurance
Other liabilities$(53)$(70)
Fixed annuities with equity indexed returns
PABs
172 163 
Total
$119 $93